合世生醫科技股份有限公司 Approved
最後更新時間 2025/07/18 , 07:18 AM
最後更新時間 2025/07/18 , 07:18 AM
負責人
Yang,Guo-He
統一編號
97304042
成立日期
1996/12/16
資本額
NT$700,000,000
實收資本額
NT$474,076,050
股票代號
1781
電話
02-82271300
地址
9F, No. 186, Jian 1st Rd., Zhonghe Dist., New Taipei City, 235, Taiwan
董監事
姓名 職稱 持有股份 代表法人
Yang,Guo-He Chairman 4.04%
Li,Shao-Hong Director 4.35%
Lian,Shu-Zhen Director 5.33%
Hong,Yu-Feng Director 1.44%
Yang,Guo-Shuo Director 1.83%
Huang,Heng-Jiang Independent Director 0.00%
Wu,Bin-An Independent Director 0.00%
Lin,Shun-Qian Independent Director 0.00%
營業項目
  • Manufacture of Other Medical Instruments and Supplies(332900)
  • Wholesale of Other Machinery and Equipment(464915)
  • 公司歷程
  • Change Capital to 700,000,000
    2020/10/16
  • 員工人數
    下載完整報告查看完整數據
    財務報表
    項目 2025 2024 2023
    Operating income 122,087 706,388 601,171
    Operating cost 88,671 558,649 508,066
    Profit (loss) of initial recognition of biological asset and agricultural products - - -
    Profit (loss) on changes in fair value less costs to sell of biological asset for current period - - -
    Operating gross profit (loss) 33,416 147,739 93,105
    Unrealized profit (loss) on sales of goods - - -
    Realized profit (loss) on sales of goods - - -
    Operating gross profit (loss), net 33,416 147,739 93,105
    Operating expenses 33,483 145,244 134,168
    Other gain (loss), net - - -
    Operating profit (loss) -67 2,495 -41,063
    Non-operating income and expenses 5,282 26,281 3,502
    Net profit (loss) before tax 5,215 28,776 -37,561
    Income tax expense (benefits) -412 4,537 -4,332
    Net profit (loss) of ongoing business for the current period 5,627 24,239 -33,229
    Profit (loss) of closed units - - -
    Profit (loss) of non-jointly controlled equity before merger - - -
    Net profit (loss) for the current period 5,627 24,239 -33,229
    Other comprehensive profit (loss), net -372 -1,657 -3,979
    Comprehensive net profit and loss of non-jointly controlled equity before merger - - -
    Total comprehensive profit and loss for the current period 5,255 22,582 -37,208
    Net profit (loss) attributable to owners of parent company 5,627 24,239 -33,229
    Net profit (loss) form equity attributable to former owner of business combination under common control - - -
    Net profit (loss) attributable to non-controlling interests - - -
    Comprehensive profit (loss) attributable to owners of parent company 5,255 22,582 -37,208
    Comprehensive profit (loss) form equity attributable to former owner of business combination under common control - - -
    Comprehensive profit (loss) attributable to non-controlling interests - - -
    Basic earnings per share (yuan) 0 0 0
    項目 2025 2024 2023
    Net cash inflow (outflow) from operating activities -14,604 33,353 84,910
    Net cash inflows (outflows) from investing activities -1,388 -89,808 -8,784
    Net cash inflow (outflow) from financing activities -4,046 128,683 -74,667
    Effect of Exchange Rate Changes on Cash and Cash Equivalents 3,852 4,075 -7,380
    Increase (decrease) in cash and cash equivalents in the current period -16,186 76,303 -5,921
    Beginning balance of cash and cash equivalents 227,022 150,719 156,640
    Ending balance of cash and cash equivalents 210,836 227,022 150,719
    項目 2025 2024 2023
    Current asset 518,563 581,088 498,566
    Non-current asset 233,543 236,174 212,222
    Total asset 752,106 817,262 710,788
    Current liability 155,228 221,743 349,359
    Non-current liability 198,572 202,468 26,059
    Total liability 353,800 424,211 375,418
    share capital 474,076 474,076 474,076
    Equity - secruity token - - -
    capital reserve 35,107 35,107 8
    retained earning -63,148 -68,593 -92,832
    Other equity -47,729 -47,539 -45,882
    Treasury stock - - -
    Total equity attributable to owners of parent company 398,306 393,051 335,370
    Equity attributable to former owner of business combination under common control - - -
    Equity attributable to non-controlling interest before business merger under common control - - -
    Non-controlling interests - - -
    Total Equity 398,306 393,051 335,370
    Share capital awaiting retirement (unit: share) 0 0 0
    Issued shares of advance equity (unit: shares) 0 0 0
    Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) 0 0 0
    Net asset value per share 8 8 7
    動產抵押
    下載完整報告查看完整數據
    案件類別 債務人名稱 債務人統編 契約啟始日期 契約終止日期 抵押權人名稱 抵押權人統編 擔保債權金額
    選舉收入(政治獻金)
    收入名稱 收入金額
    總收入金額
    選舉支出(政治獻金)
    支出名稱 支出金額
    總支出金額
    標案拒往
    機關名稱 生效日期 截止日期
    進出口資料
    下載完整報告查看完整數據
    年份 月份 總進口實績(美金) 總出口實績(美金)
    商標
  • Health & Life設計圖
  • 凱優
  • Health&Life
  • 瑞康
  • H&L
  • 專利
    政府標案
    標案名稱 機關名稱 決標日期 決標金額 是否得標
    裁判書查詢
  • Copyright Law
    2022
  • Pay for the goods
    2023
  • Others
    2016, 2018
  • Payment order
    2023
  • Payment, etc.
    2023
  • Invalidating Judgment
    2004
  • 勞權違規
    日期 違反法規法條 罰鍰金額
    污染源裁處
    污染類別 裁處時間 裁處機關 裁處金額 違反事實 違反法令 裁處書字號 裁處理由及法令 公司地址
    本頁內所載之資料,所載資料之完整性、即時性和正確性仍應以資料來源單位為準。
    公司一有新動態,我們馬上通知你,追蹤公司讓你不錯過任何更新。